Acute Inhibition of Cardiac Monoamine Oxidase A after Tobacco Smoke Inhalation: Validation Study of [11C]Befloxatone in Rats Followed by a Positron Emission Tomography Application in Baboons
Authors:
- Héric ValetteHVHéric Valette
- Frédéric DolléFDFrédéric Dollé
- Michèle OttavianiMOMichèle Ottaviani
- André SyrotaASAndré Syrota
Open Access
- 1 July 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 314 (1) , 431-436
Abstract
The in vivo characteristics of [11C]befloxatone were assessed in myocardium of rats and monkeys. A complete multicompartmental model was developed to quantify monkey cardiac monoamine oxidase A (MAO-A) binding sites using positron emission tomography (PET) and was applied to assess the acute effects of inhalation of tobacco smoke. Unknown compounds contained in tobacco smoke inhibit brain MAO. In vitro, befloxatone inhibits selectively, competitively, and reversibly MAO-A in human tissues. [11C]Befloxatone (1.85 MBq) was i.v. injected into rats. Animals were sacrificed, dissected, and samples were assessed for radioactivity. Another group of rats was pretreated with clorgyline (10 mg/kg i.v.). Monkeys were injected with [11C]befloxatone (222–370 MBq), and the chest was imaged with PET for 2 h. Presaturation and displacement experiments were performed using unlabeled befloxatone. For quantification of myocardial binding sites (Bmax), [11C]befloxatone was first injected as a tracer dose (2.7–9.3 nmol) and 20 min later injected as a mixture of labeled and unlabeled befloxatone (labeled, 10.3–41.9 nmol; unlabeled, 407–765 nmol). In rodents, cardiac uptake was high (3.39 ± 0.5% injected dose/g tissue) and strongly inhibited (80%) by clorgyline. In monkeys, administration of unlabeled befloxatone displaced 85% of cardiac radioactivity. Bmax was found to be 208 ± 13 pmol ml-1 tissue. Inhalation of tobacco smoke decreased Bmax: 150 ± 6.2 pmol ml-1, whereas nicotine did not. [11C]Befloxatone allows a good visualization of the heart. Cardiac MAO-A Bmax was quantified and a clear effect of acute inhalation of tobacco smoke was evidenced. Therefore, a single cigarette can interfere with the cardiac turnover of catecholamines.Keywords
This publication has 30 references indexed in Scilit:
- Catecholamine Metabolism: A Contemporary View with Implications for Physiology and MedicinePharmacological Reviews, 2004
- Comparison of the binding of the irreversible monoamine oxidase tracers, [11C]clorgyline and [11C]l-deprenyl in brain and peripheral organs in humansNuclear Medicine and Biology, 2004
- Monoamine oxidase A imaging in peripheral organs in healthy human subjectsSynapse, 2003
- Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]BefloxatoneThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Inhibition of monoamine oxidase B in the brains of smokersNature, 1996
- Modeling Analysis of [11C]Flumazenil Kinetics Studied by PET: Application to a Critical Study of the Equilibrium ApproachesJournal of Cerebral Blood Flow & Metabolism, 1993
- Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brainLife Sciences, 1991
- Pharmacologic Aspects of Cigarette Smoking and Nicotine AddictionNew England Journal of Medicine, 1988
- Irreversible inhibition of monoamine oxidase by some components of cigarette smokeLife Sciences, 1987
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974